Archive

Multimodal analgesia – the standard of care

Written by | 23 Feb 2022

Multimodal analgesia is now the standard of care for post-operative pain relief and it can readily be explained to patients, says Dr Alexander Tzabazis, Deputy Director of Anaesthesiology […]

IV non-opioid analgesics and ERAS – the evidence

Written by | 22 Feb 2022

There is now extensive evidence to support the multimodal approach to peri-operative pain relief and the role of intravenous paracetamol and ibuprofen, according to Dr Alexander Tzabazis, Deputy […]

Enhanced recovery after surgery and the maximodal approach

Written by | 21 Feb 2022

Enhanced recovery after surgery (ERAS) offers many advantages including early functional recovery and reduced exposure to opioids.  IMI spoke to Dr Alexander Tzabazis, Deputy Director of Anaesthesiology and […]

Implications of findings for disease flare and vaccine reactions in RMD patients

Written by | 8 Feb 2022

With low rates of disease flare and reactogenicity after vaccination, the study findings are reassuring for both patients and clinicians, according to Dr Caoilfhionn Connolly, Rheumatology Fellow at […]

Disease flare and reactogenicity after covid vaccination in RMD patients

Written by | 7 Feb 2022

A recent study at Johns Hopkins evaluated responses to SARS-CoV-2 vaccination in patients with rheumatoid and musculoskeletal disease (RMD)1 – a group that was poorly represented in the […]

Primary care network pharmacy – making it work

Written by | 28 Jan 2022

Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN describes how some critical factors need to be taken into account when planning and organising PCN pharmacy […]

RCT of medicines optimisation in general practice

Written by | 27 Jan 2022

Steve Williams, Senior Clinical Pharmacist at Poole Bay and Bournemouth PCN explains the positive findings from a randomised controlled trial that evaluated the impact of a medicines’ optimisation […]

What does a PCN pharmacist do?

Written by | 26 Jan 2022

The day-to-day work of a pharmacist in a Primary Care Network (PCN) embraces operational and strategic elements and this involves working closely with other members of the primary […]

Getting started as a PCN pharmacist

Written by | 25 Jan 2022

The NHS long term plan foresees the establishment of teams of clinical pharmacists in every primary care network (PCN). IMI spoke to Steve Williams, a senior clinical pharmacist […]

What pharmacists need to know about cannabidiol

Written by | 8 Jan 2022

Community pharmacists can be an important source of information about cannabidiol (CBD) but they also need to ensure that the CBD products that they sell are correctly licensed […]

Dosing and administration of cannabidiol

Written by | 7 Jan 2022

Natural cannabidiol distillate is superior to synthetic CBD because of the benefits of the ‘entourage effect’, according to Moyra Cosgrove, Head of Nutrition for Naturecan, a company that […]

Cannabidiol and why we need to take it seriously

Written by | 6 Jan 2022

There is a growing body of evidence for the effectiveness of cannabidiol (CBD) in a number of health conditions. To find out more, IMI spoke to Moyra Cosgrove, […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.